Meridian Clinical Research Opens Dedicated Research Center in Sioux City, IA

Meridian Clinical Research, a leading multi-specialty investigative research network, has opened a dedicated research center at 4802 Sunnybrook Drive in Sioux City, IA.
 

Since 2005, Meridian has conducted clinical trials at a site in Dakota Dunes, SD. All Dakota Dunes personnel and studies will be moved to the new site in Sioux City, where David Ensz, MD, will continue to serve as the principal investigator for clinical trials.

The move is a result of continued growth for the company, which was founded in 1999 and now operates at 23 locations nationwide. “This is a significant milestone for Dr. Ensz and our staff, and the move will give our Sioux City team room to develop even further,” said Nicole Osborn, founder and CEO of Meridian.
 

Meridian’s facility in Sioux City will be several times larger than its prior office, and will house a larger clinical staff and a new call center an on-site peripheral blood mononuclear cell (PBMC) processing laboratory. As a result, the Sioux City site is now hiring for many clinical and administrative roles. “We’re growing, and we’re always looking for talented people who share our ambition to advance human health,” said Osborn. “Clinical research is challenging, but it is also highly rewarding in that we can improve the lives of millions.” If you’re interested in a career with Meridian, visit mcrmed.com/careers.
 

Meridian is currently enrolling participants for numerous COVID-19 vaccine trials at sites nationwide, including its Sioux City location. In October, officials from the U.S. Department of Health and Human Services (HHS) held a roundtable discussion with Meridian leaders to discuss patient recruitment efforts and the research the company has conducted for COVID-19 vaccine

clinical trials nationwide. The company also recently earned 2020 Vaccine Industry Excellence (ViE) awards for Best Clinical Trial Site and Best Clinical Trial Network, the latter as the largest member of Platinum Research Network. Meridian’s Sioux City site will continue to support vaccine trials for infectious diseases.
 

To learn about current clinical trials Meridian is conducting in Sioux City, visit mcrmed.com/find-study.

 

 

Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is a multi-specialty site network headquartered at its dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials.